Dr. Whiting is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Ambulatory Clinic
Seattle, WA 98109Phone+1 206-288-1000
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2001 - 2005- University of WashingtonResidency, Internal Medicine, 1999 - 2001
- University of Washington School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2024 - 2026
WA State Medical License 2001 - 2025
Clinical Trials
- Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2016 Aug 01
- Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC) Start of enrollment: 2017 May 01
- CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) Start of enrollment: 2017 Sep 06
- Join now to see all
Press Mentions
Hyatt Hotel Heir Donates $60 Million for UCSF Psychiatric HospitalMay 12th, 2021- ‘In the Abyss’: Why Bay Area Health Care Experts Fear JanuaryJanuary 3rd, 2021
- PeopleDecember 3rd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
